VNDA
Vanda Pharmaceuticals Inc
NASDAQ: VNDA · HEALTHCARE · BIOTECHNOLOGY
$7.10
+0.71% today
Updated 2026-04-30
Market cap
$411.32M
P/E ratio
—
P/S ratio
1.90x
EPS (TTM)
$-3.74
Dividend yield
—
52W range
$4 – $10
Volume
2.8M
Vanda Pharmaceuticals Inc (VNDA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $4.55M | $35.22M | $31.27M | $32.73M | $33.88M | $50.16M | $109.92M | $146.02M | $165.08M | $193.12M | $227.19M | $248.17M | $268.68M | $254.38M | $192.64M | $198.77M | $216.10M |
| Revenue growth (YoY) | — | — | — | — | +674.4% | -11.2% | +4.7% | +3.5% | +48.0% | +119.2% | +32.8% | +13.1% | +17.0% | +17.6% | +9.2% | +8.3% | -5.3% | -24.3% | +3.2% | +8.7% |
| Cost of revenue | — | $79.47M | $52.31M | $2.90M | $4.39M | $40.01M | $129000.00 | $52.35M | $1.58M | $23.46M | $24.71M | $17.85M | $20.51M | $24.49M | $23.36M | $25.63M | $24.28M | $17.57M | $11.31M | $13.04M |
| Gross profit | — | — | — | $1.65M | $30.83M | $31.27M | $32.60M | $33.88M | $48.57M | $86.46M | $121.31M | $147.24M | $172.61M | $202.70M | $224.80M | $243.05M | $230.10M | $192.64M | $187.46M | $203.06M |
| Gross margin | — | — | — | 36.3% | 87.5% | 100.0% | 99.6% | 100.0% | 96.8% | 78.7% | 83.1% | 89.2% | 89.4% | 89.2% | 90.6% | 90.5% | 90.5% | 100.0% | 94.3% | 94.0% |
| R&D | $52.07M | $47.23M | $23.94M | $13.87M | $12.34M | $29.00M | $45.45M | $28.19M | $19.23M | $29.14M | $29.16M | $38.55M | $43.59M | $48.65M | $55.58M | $75.36M | $85.77M | $76.82M | $74.43M | $109.27M |
| SG&A | $13.64M | $32.80M | $28.91M | $23.72M | $10.15M | $11.49M | $13.88M | $24.59M | $79.64M | $81.13M | $98.39M | $122.54M | $105.75M | $126.54M | $127.91M | $117.35M | $133.88M | $122.05M | $144.51M | $237.95M |
| Operating income | $-65.71M | $-80.04M | $-52.85M | $-35.95M | $8.35M | $-10.71M | $-28.23M | $-20.40M | $20.06M | $-40.19M | $-18.57M | $-16.90M | $21.74M | $22.81M | $27.24M | $42.16M | $6.33M | $-13.95M | $-40.66M | $-151.17M |
| Operating margin | — | — | — | -790.5% | 23.7% | -34.2% | -86.2% | -60.2% | 40.0% | -36.6% | -12.7% | -10.2% | 11.3% | 10.0% | 11.0% | 15.7% | 2.5% | -7.2% | -20.5% | -70.0% |
| EBITDA | $-62.93M | $-73.49M | $-50.53M | $-34.52M | $10.67M | $-9.67M | $-27.05M | $-19.27M | $-54.77M | $-26.63M | $-6.70M | $-13.92M | $24.69M | $25.70M | $34.52M | $45.01M | $9.06M | $-13.95M | $-32.53M | $-139.25M |
| EBITDA margin | — | — | — | -759.1% | 30.3% | -30.9% | -82.7% | -56.9% | -109.2% | -24.2% | -4.6% | -8.4% | 12.8% | 11.3% | 13.9% | 16.8% | 3.6% | -7.2% | -16.4% | -64.4% |
| EBIT | $-63.51M | $-74.06M | $-51.06M | $-35.95M | $8.84M | $-11.17M | $-28.55M | $-20.77M | $-57.02M | $-39.60M | $-18.57M | $-16.90M | $21.74M | $22.81M | $31.66M | $42.16M | $6.33M | $-13.95M | $-40.66M | $-151.17M |
| Interest expense | $4833.00 | $0.00 | $0.00 | $97.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $6.22M | $4.42M | $199000.00 | $4.97M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-63.51M | $-74.07M | $-51.06M | $-35.86M | $7.19M | $-9.80M | $-27.66M | $-20.25M | $20.19M | $-39.87M | $-18.01M | $-15.57M | $25.21M | $115.55M | $23.34M | $33.15M | $6.28M | $2.51M | $-18.90M | $-220.47M |
| Net income growth (YoY) | — | -16.6% | +31.1% | +29.8% | +120.1% | -236.3% | -182.2% | +26.8% | +199.7% | -297.5% | +54.8% | +13.6% | +261.9% | +358.4% | -79.8% | +42.1% | -81.1% | -60.0% | -853.3% | -1066.5% |
| Profit margin | — | — | — | -788.5% | 20.4% | -31.3% | -84.5% | -59.8% | 40.2% | -36.3% | -12.3% | -9.4% | 13.1% | 50.9% | 9.4% | 12.3% | 2.5% | 1.3% | -9.5% | -102.0% |